Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications.
about
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosisPerformance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.Invasive fungal infections in transplant recipientsPharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United StatesPrognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosisHost biomarkers of invasive pulmonary aspergillosis to monitor therapeutic responseEarly Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapyUpdate on the laboratory diagnosis of invasive fungal infectionsClinical utility and development of biomarkers in invasive aspergillosis.Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definitionGalactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis.Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detectionProspective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patientsPulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.Early serum galactomannan trend as a predictor of outcome of invasive aspergillosisSerum galactomannan levels in the diagnosis of invasive aspergillosis.Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?Diagnostic methods for invasive fungal diseases in patients with hematologic malignanciesSerum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation.Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeSuccess rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in KoreaSuccessful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole.Detection and investigation of invasive mould disease.The impact of azole resistance on aspergillosis guidelines.Advancing the Field: Evidence for New Management Strategies in Invasive Fungal InfectionsNon-cultural methods for the diagnosis of invasive fungal disease.Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis.Atypical Presentation of Isolated Cerebral Aspergillosis in a Renal Allograft Recipient.Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.Treatment of Disseminated Aspergillosis with Posaconazole in 10 Dogs.Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities.
P2860
Q28727508-FCC496BD-0926-4177-993A-86541C2CE701Q31120454-DC54BAB5-356D-4EC8-A123-E8181B840016Q33695215-E2795C81-62BB-40F5-B712-3F96884407C1Q33696043-D8590600-EC9F-404C-A434-F35A9DAF6EB3Q33703566-8455D003-0376-478F-AAF1-4F347D0D4EC7Q33769712-3A965BDA-027E-440B-8DE8-BF8968A48EC7Q33798161-C5C54C25-9C4F-4446-98E4-441C6F118AF2Q34052696-D042AF4F-F548-4C06-B366-F6BAA1FEA247Q34532546-24121887-AD9D-4EBC-BAC2-550E2078E0FBQ34754956-AEA940CA-BC5E-4AD8-8333-A289FB36B4FEQ35010667-AB9B2022-3ECB-47BB-A496-3580FD3CAB89Q35049005-8918E7FA-D390-49C6-B4DA-0FAB177B2321Q35194409-4C4FD17E-B492-4E26-A60B-D58986393705Q35598876-C98BF37C-E807-4BE7-ADAB-CC4C88AEE8EEQ35672970-1296A569-5315-42F0-BF35-74ACBDD81175Q35689788-7116B6C1-19C3-4A18-8C67-74EA384AC19DQ35806998-9229A5EC-73AE-41C4-8D86-46572945C76CQ35807013-A0D65395-7117-4E91-AC99-58609A8BB472Q35889014-2B27D2EB-EB32-4272-887D-A508273435CEQ36115615-10960D20-9BDD-4517-9D8F-F2BF19671BF9Q36118619-19828D29-F95A-4FC8-9A0A-E20E3DE09F2DQ36272128-ADB0ABE0-52D3-45EA-AD50-91A2435212EEQ36443067-89C884BB-4DAB-453A-837F-BCB1DCFBA613Q36584898-C410A6FE-AA68-44C8-BC3A-3527889D83B7Q37150921-6DD3B1CE-ACB3-46DF-B68F-BC5BC045D945Q37287794-D2A4BEC4-0CBE-4605-9889-7F829B49D4E9Q37473671-57C39FF4-D522-4E04-B4B8-5AC5FADACD90Q37738989-ABBE6B05-BADC-4004-BEBB-4A75166874CCQ37823011-ADC24774-04BC-4D1D-BD5C-0283044F946DQ38066615-4FE8DCEE-013C-41F4-8500-15763C3DC535Q38082740-0432A4CA-3CBE-43F9-991E-B132C47B70FAQ38266817-77F4EA22-3FDD-40AC-81E3-A62550CD4C68Q38284458-EFA23D6E-9DF9-4590-8DAC-116154450A58Q38508539-F23B2830-D36A-434C-BD58-A4AB63AA0DE1Q38738090-0E05716C-1135-4FCE-A6AB-F9134A06AAFBQ39127825-3E9F895C-7453-4E86-B3F4-7392CA0A4497Q40053510-592B6F9D-57EC-4550-A0E9-1EADE53F51F5Q40140001-940FCEA1-1A03-4702-BBB2-C0D710E4DB12Q40323166-4C8DDC3D-81F9-4235-9485-D71A3547D24EQ40349447-817119BE-E666-41E2-9794-6F4A203C7DAE
P2860
Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Strong correlation between ser ...... cal and research implications.
@en
Strong correlation between ser ...... cal and research implications.
@nl
type
label
Strong correlation between ser ...... cal and research implications.
@en
Strong correlation between ser ...... cal and research implications.
@nl
prefLabel
Strong correlation between ser ...... cal and research implications.
@en
Strong correlation between ser ...... cal and research implications.
@nl
P2093
P2860
P356
P1476
Strong correlation between ser ...... cal and research implications.
@en
P2093
Gail Woods
Marisa H Miceli
Mehmet H Kocoglu
Monica L Grazziutti
Weizhi Zhao
P2860
P304
P356
10.1086/528714
P407
P577
2008-05-01T00:00:00Z